R. Kirwan

Ibrexafungerp: an orally active β-1,3-glucan synthesis inhibitor.

P. Liberator, M. Motyl, M. Peel, 2020, Bioorganic & medicinal chemistry letters.

MK-5204: An orally active β-1,3-glucan synthesis inhibitor.

P. Liberator, M. Motyl, M. Peel, 2020, Bioorganic & medicinal chemistry letters.

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin.

P. Liberator, M. Motyl, M. Peel, 2015, Bioorganic & medicinal chemistry letters.